☆ 4.7 Meeting Abstract

A phase II, multicenter, single-arm study of parsaclisib, a PI3K delta inhibitor, in relapsed or refractory follicular lymphoma in China: Updated data from the study.

JOURNAL OF CLINICAL ONCOLOGY (2022)

主要评分表示论文的整体质量水平。次要评分独立反映论文的优点或缺点。

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started